PRESS RELEASE
23 June 2026

Goodwin Advises Sapio On The Acquisition Of EXPERF

GP
Goodwin Procter LLP

Contributor

At Goodwin, we partner with our clients to practice law with integrity, ingenuity, agility, and ambition. Our 1,600 lawyers across the United States, Europe, and Asia excel at complex transactions, high-stakes litigation and world-class advisory services in the technology, life sciences, real estate, private equity, and financial industries. Our unique combination of deep experience serving both the innovators and investors in a rapidly changing, technology-driven economy sets us apart.
The Paris Private Equity team advised Sapio Santé France SAS, a French subsidiary of the Sapio Group, on the acquisition from French group Bastide of New Medical...
France

The Paris Private Equity team advised Sapio Santé France SAS, a French subsidiary of the Sapio Group, on the acquisition from French group Bastide of New Medical Concept, the holding company of the EXPERF Group, a home healthcare provider specializing in home infusion and nutrition services.

With an extensive network of 28 agencies and revenue of more than €42 million, EXPERF specializes in home infusion and clinical nutrition, including immunotherapy, Parkinson’s disease, and diabetes treatments.

The transaction enables Sapio to position itself in France as one of the leading players in home infusion care and to strengthen its leadership in home nutrition. It is part of the group’s strategic plan to pursue sustainable growth in Europe and consolidate its position in the healthcare sector.

The Goodwin team included Thomas Maitrejean, Rodolphe Amaudric du Chaffaut, Ronan Pflieger, and Marjorie Ladsous on corporate aspects, and Marie Fillon and Albana Taipi on intellectual property aspects.

Contributor

At Goodwin, we partner with our clients to practice law with integrity, ingenuity, agility, and ambition. Our 1,600 lawyers across the United States, Europe, and Asia excel at complex transactions, high-stakes litigation and world-class advisory services in the technology, life sciences, real estate, private equity, and financial industries. Our unique combination of deep experience serving both the innovators and investors in a rapidly changing, technology-driven economy sets us apart.

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More